Cardiac Effects of Opioid Therapy

The QTc Effect of Low-Dose Methadone for Chronic Pain: A Prospective Pilot Study

(2015) Samuel Grodofsky et al.   PAIN MEDICINE

The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue

(2014) Piotr Sobanski et al.   HEART AND VESSELS

Methadone Safety: A Clinical Practice Guideline From the American Pain Society and College on Problems of Drug Dependence, in Collaboration With the Heart Rhythm Society

(2014) Roger Chou et al.   JOURNAL OF PAIN

Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort

(2011) Wendy J. Carman et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Prolonged Sinus Pauses with Hydromorphone in the Absence of Cardiac Conduction Disease

(2011) Brian S. Snarr et al.   SOUTHERN MEDICAL JOURNAL

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

(2010) Marc Afilalo et al.   CLINICAL DRUG INVESTIGATION

Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activityin vitro

(2008) Søren Fanoe et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Drug-induced serotonin syndrome: a review

(2008) Christina Sun-Edelstein et al.   Expert Opinion On Drug Safety